Addex Therapeutics ADXN
NASDAQ ADXN
$3.07 +0.09 (+3.02%)
At close: Oct 2, 2026 · 4:00 PM EDT

Addex Therapeutics (ADXN) Beginning Cash Balance (2019 - 2026)

Updated

Addex Therapeutics' Beginning Cash Balance came in at $2.09 million for Q1 2026, down 43.7% from $3.72 million a year earlier.

Analysis

Addex Therapeutics (ADXN) Beginning Cash Balance (2019 - 2026) Analysis & Trends

Over the trailing twelve months to Mar 31, 2026, Addex Therapeutics reported Beginning Cash Balance of $5.81 million, down 28.7% year-over-year.

  • The Q1 2026 figure represents the lowest quarterly Beginning Cash Balance since Q3 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Addex Therapeutics 2.47 Mn 2.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 2.09 Mn
Mar 31, 2025 3.72 Mn
Mar 31, 2024 4.43 Mn
Mar 31, 2023 7.52 Mn
Mar 31, 2022 22.18 Mn
Mar 31, 2021 20.68 Mn
Mar 31, 2020 32.60 Mn
Sep 30, 2019 160.36
Mar 31, 2019 41.84 Mn
API Access

Addex Therapeutics Beginning Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=beginning-cash-balance&ticker=ADXN&period=max&api_key=YOUR_API_KEY